

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.15984150 |
| 2 | nucleobase catabolic process (GO:0046113) | 5.11386196 |
| 3 | gamma-aminobutyric acid transport (GO:0015812) | 4.13106708 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.00780038 |
| 5 | neural tube formation (GO:0001841) | 3.95890132 |
| 6 | vocalization behavior (GO:0071625) | 3.90044368 |
| 7 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.82394441 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.76973681 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 3.75204641 |
| 10 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.66833948 |
| 11 | presynaptic membrane assembly (GO:0097105) | 3.64151198 |
| 12 | startle response (GO:0001964) | 3.63003691 |
| 13 | detection of calcium ion (GO:0005513) | 3.60181908 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.57222227 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 3.56654383 |
| 16 | protein localization to cilium (GO:0061512) | 3.53017039 |
| 17 | auditory behavior (GO:0031223) | 3.51959111 |
| 18 | synaptic transmission, glutamatergic (GO:0035249) | 3.48161181 |
| 19 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.46285774 |
| 20 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.44524047 |
| 21 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.42825959 |
| 22 | establishment of protein localization to Golgi (GO:0072600) | 3.40375291 |
| 23 | protein polyglutamylation (GO:0018095) | 3.38322583 |
| 24 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.38110971 |
| 25 | prostate gland growth (GO:0060736) | 3.37396416 |
| 26 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.36111144 |
| 27 | neuron recognition (GO:0008038) | 3.34535587 |
| 28 | presynaptic membrane organization (GO:0097090) | 3.31684688 |
| 29 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.29859777 |
| 30 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.28438196 |
| 31 | axonal fasciculation (GO:0007413) | 3.27455700 |
| 32 | protein localization to synapse (GO:0035418) | 3.27305302 |
| 33 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.27246811 |
| 34 | neuron-neuron synaptic transmission (GO:0007270) | 3.26450752 |
| 35 | synaptic vesicle exocytosis (GO:0016079) | 3.25471130 |
| 36 | glutamate receptor signaling pathway (GO:0007215) | 3.23900307 |
| 37 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.19951901 |
| 38 | epithelial cilium movement (GO:0003351) | 3.19631867 |
| 39 | postsynaptic membrane organization (GO:0001941) | 3.19428555 |
| 40 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.18334855 |
| 41 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.17725115 |
| 42 | innervation (GO:0060384) | 3.16059345 |
| 43 | neuronal ion channel clustering (GO:0045161) | 3.15399542 |
| 44 | dendritic spine morphogenesis (GO:0060997) | 3.14506665 |
| 45 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.12646174 |
| 46 | synaptic vesicle maturation (GO:0016188) | 3.12464392 |
| 47 | regulation of cilium movement (GO:0003352) | 3.09556463 |
| 48 | acrosome reaction (GO:0007340) | 3.08305226 |
| 49 | response to pheromone (GO:0019236) | 3.08066632 |
| 50 | protein targeting to Golgi (GO:0000042) | 3.06677186 |
| 51 | retinal cone cell development (GO:0046549) | 3.05452927 |
| 52 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.04265667 |
| 53 | glutamate secretion (GO:0014047) | 3.02843054 |
| 54 | detection of light stimulus involved in visual perception (GO:0050908) | 3.02646052 |
| 55 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.02646052 |
| 56 | olfactory bulb development (GO:0021772) | 3.01732366 |
| 57 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.01699860 |
| 58 | synaptic vesicle endocytosis (GO:0048488) | 3.00873154 |
| 59 | nerve growth factor signaling pathway (GO:0038180) | 3.00529356 |
| 60 | glycosphingolipid biosynthetic process (GO:0006688) | 2.99899027 |
| 61 | tachykinin receptor signaling pathway (GO:0007217) | 2.98801142 |
| 62 | establishment of mitochondrion localization (GO:0051654) | 2.97095694 |
| 63 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.96173728 |
| 64 | striatum development (GO:0021756) | 2.94194592 |
| 65 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.91024358 |
| 66 | mechanosensory behavior (GO:0007638) | 2.89918824 |
| 67 | neurofilament cytoskeleton organization (GO:0060052) | 2.89423958 |
| 68 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.86401322 |
| 69 | sympathetic nervous system development (GO:0048485) | 2.84265862 |
| 70 | dendrite morphogenesis (GO:0048813) | 2.75630515 |
| 71 | cilium movement (GO:0003341) | 2.75509306 |
| 72 | cerebellum development (GO:0021549) | 2.75297715 |
| 73 | cAMP-mediated signaling (GO:0019933) | 2.72871416 |
| 74 | vesicle localization (GO:0051648) | 2.72522216 |
| 75 | regulation of action potential (GO:0098900) | 2.71976101 |
| 76 | adult walking behavior (GO:0007628) | 2.71891891 |
| 77 | behavioral response to ethanol (GO:0048149) | 2.71638631 |
| 78 | synapse assembly (GO:0007416) | 2.71054614 |
| 79 | retinal ganglion cell axon guidance (GO:0031290) | 2.71015989 |
| 80 | neuronal action potential propagation (GO:0019227) | 2.70879835 |
| 81 | positive regulation of synapse maturation (GO:0090129) | 2.70391218 |
| 82 | proline transport (GO:0015824) | 2.70258442 |
| 83 | insulin secretion (GO:0030073) | 2.70097361 |
| 84 | regulation of sarcomere organization (GO:0060297) | 2.68756431 |
| 85 | serotonin metabolic process (GO:0042428) | 2.67952453 |
| 86 | righting reflex (GO:0060013) | 2.67610897 |
| 87 | positive regulation of amino acid transport (GO:0051957) | 2.66218300 |
| 88 | regulation of synapse maturation (GO:0090128) | 2.65177350 |
| 89 | regulation of synapse assembly (GO:0051963) | 2.64699178 |
| 90 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.64222613 |
| 91 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.63795541 |
| 92 | hindbrain development (GO:0030902) | 2.63249459 |
| 93 | regulation of collateral sprouting (GO:0048670) | 2.62024598 |
| 94 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.61574113 |
| 95 | long-term memory (GO:0007616) | 2.60935122 |
| 96 | cilium assembly (GO:0042384) | 2.60544341 |
| 97 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.60490573 |
| 98 | dentate gyrus development (GO:0021542) | 2.60418114 |
| 99 | dendritic spine organization (GO:0097061) | 2.59938497 |
| 100 | regulation of microtubule-based movement (GO:0060632) | 2.58592287 |
| 101 | calcium ion import (GO:0070509) | 2.58366695 |
| 102 | cilium organization (GO:0044782) | 2.57960020 |
| 103 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.57932959 |
| 104 | membrane hyperpolarization (GO:0060081) | 2.57256441 |
| 105 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.57030084 |
| 106 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.57030084 |
| 107 | urinary tract smooth muscle contraction (GO:0014848) | 2.56972524 |
| 108 | regulation of feeding behavior (GO:0060259) | 2.56352069 |
| 109 | behavioral response to nicotine (GO:0035095) | 2.56154096 |
| 110 | positive regulation of synapse assembly (GO:0051965) | 2.56112114 |
| 111 | cochlea development (GO:0090102) | 2.56064108 |
| 112 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.55571092 |
| 113 | calcium ion-dependent exocytosis (GO:0017156) | 2.55554014 |
| 114 | retina layer formation (GO:0010842) | 2.55439841 |
| 115 | photoreceptor cell maintenance (GO:0045494) | 2.54947004 |
| 116 | response to auditory stimulus (GO:0010996) | 2.54778704 |
| 117 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.54717876 |
| 118 | locomotory exploration behavior (GO:0035641) | 2.53903501 |
| 119 | regulation of postsynaptic membrane potential (GO:0060078) | 2.53837332 |
| 120 | protein localization to Golgi apparatus (GO:0034067) | 2.52867776 |
| 121 | regulation of neurotransmitter secretion (GO:0046928) | 2.52253078 |
| 122 | reflex (GO:0060004) | 2.51706630 |
| 123 | intraciliary transport (GO:0042073) | 2.51438257 |
| 124 | negative regulation of mast cell activation (GO:0033004) | 2.50153670 |
| 125 | nonmotile primary cilium assembly (GO:0035058) | 2.50110094 |
| 126 | organelle transport along microtubule (GO:0072384) | 2.49941138 |
| 127 | establishment of melanosome localization (GO:0032401) | 2.49918688 |
| 128 | vesicle transport along microtubule (GO:0047496) | 2.48943667 |
| 129 | neurotransmitter secretion (GO:0007269) | 2.48648333 |
| 130 | transmission of nerve impulse (GO:0019226) | 2.48450416 |
| 131 | regulation of vesicle fusion (GO:0031338) | 2.47882297 |
| 132 | dendrite development (GO:0016358) | 2.47752551 |
| 133 | response to histamine (GO:0034776) | 2.46938411 |
| 134 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.45595206 |
| 135 | negative regulation of dendrite development (GO:2000171) | 2.44634321 |
| 136 | membrane depolarization during action potential (GO:0086010) | 2.44260546 |
| 137 | interkinetic nuclear migration (GO:0022027) | 2.44092293 |
| 138 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.42934108 |
| 139 | long-term synaptic potentiation (GO:0060291) | 2.42599068 |
| 140 | cell migration in hindbrain (GO:0021535) | 2.41571797 |
| 141 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.39144255 |
| 142 | regulation of respiratory system process (GO:0044065) | 2.38418075 |
| 143 | somite development (GO:0061053) | 2.37226259 |
| 144 | central nervous system neuron axonogenesis (GO:0021955) | 2.37197980 |
| 145 | neuronal action potential (GO:0019228) | 2.36876450 |
| 146 | cyclic nucleotide catabolic process (GO:0009214) | 2.36126211 |
| 147 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.35703823 |
| 148 | positive regulation of membrane potential (GO:0045838) | 2.35281199 |
| 149 | photoreceptor cell differentiation (GO:0046530) | 2.34923356 |
| 150 | eye photoreceptor cell differentiation (GO:0001754) | 2.34923356 |
| 151 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.34657699 |
| 152 | regulation of keratinocyte proliferation (GO:0010837) | 2.33729448 |
| 153 | synaptic vesicle transport (GO:0048489) | 2.33253793 |
| 154 | establishment of synaptic vesicle localization (GO:0097480) | 2.33253793 |
| 155 | cell differentiation in hindbrain (GO:0021533) | 2.33103363 |
| 156 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.31349191 |
| 157 | cAMP catabolic process (GO:0006198) | 2.30148436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.04498797 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.01569474 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.61065127 |
| 4 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.52941989 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.47003305 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.28384066 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.24564625 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.21491565 |
| 9 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.15992826 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.14022561 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.13345987 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.12308182 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.08008386 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.07754377 |
| 15 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.07582459 |
| 16 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.03486827 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.01730713 |
| 18 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.93276045 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.92661486 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.92339468 |
| 21 | P300_19829295_ChIP-Seq_ESCs_Human | 1.88348370 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.87777098 |
| 23 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.87283279 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.86716937 |
| 25 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.85599715 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.80845582 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.80346592 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.80163869 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78818823 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.78815550 |
| 31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.78815550 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77048024 |
| 33 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.75816118 |
| 34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.75775426 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.75567195 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73032363 |
| 37 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.72427132 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.70467358 |
| 39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.68936838 |
| 40 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.67849384 |
| 41 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.66759422 |
| 42 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.66013783 |
| 43 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.65579019 |
| 44 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.65579019 |
| 45 | STAT3_23295773_ChIP-Seq_U87_Human | 1.62884452 |
| 46 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.59094899 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.57668364 |
| 48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.57386774 |
| 49 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.56019905 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55213835 |
| 51 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.54468379 |
| 52 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52860676 |
| 53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.51503041 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.51156857 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50864055 |
| 56 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.49904545 |
| 57 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.48354864 |
| 58 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.46512755 |
| 59 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.45500897 |
| 60 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45500897 |
| 61 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.41358452 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40575479 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.39798675 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 1.39555922 |
| 65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38396204 |
| 66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38315800 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37194192 |
| 68 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.33707248 |
| 69 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.32878567 |
| 70 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32304961 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29576649 |
| 72 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29355782 |
| 73 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.28982268 |
| 74 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.28957315 |
| 75 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27116479 |
| 76 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.26868040 |
| 77 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.26763055 |
| 78 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.26629973 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.25614592 |
| 80 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.24410716 |
| 81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21695536 |
| 82 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.21573228 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20219742 |
| 84 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.20023419 |
| 85 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.19931546 |
| 86 | AR_19668381_ChIP-Seq_PC3_Human | 1.19503455 |
| 87 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.19433758 |
| 88 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.18835324 |
| 89 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17829130 |
| 90 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17601160 |
| 91 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.17528878 |
| 92 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.17523970 |
| 93 | KDM2B_26808549_Chip-Seq_REH_Human | 1.17251185 |
| 94 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15504850 |
| 95 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14565270 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14388306 |
| 97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13981101 |
| 98 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.13730049 |
| 99 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.12846597 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11179778 |
| 101 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10706588 |
| 102 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.10602717 |
| 103 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10288320 |
| 104 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09938097 |
| 105 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08717005 |
| 106 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08570626 |
| 107 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08402924 |
| 108 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08182491 |
| 109 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07769184 |
| 110 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07458905 |
| 111 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06702026 |
| 112 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.06180683 |
| 113 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.05837427 |
| 114 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05375404 |
| 115 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04893421 |
| 116 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04062906 |
| 117 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02690040 |
| 118 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.01442273 |
| 119 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01203657 |
| 120 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01203657 |
| 121 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01169146 |
| 122 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.00359208 |
| 123 | JUN_21703547_ChIP-Seq_K562_Human | 0.97014604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001188_hyperpigmentation | 3.09356753 |
| 2 | MP0010386_abnormal_urinary_bladder | 3.05894580 |
| 3 | MP0003122_maternal_imprinting | 2.93960550 |
| 4 | MP0006292_abnormal_olfactory_placode | 2.85723323 |
| 5 | MP0003787_abnormal_imprinting | 2.85369941 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 2.82814606 |
| 7 | MP0005646_abnormal_pituitary_gland | 2.71592231 |
| 8 | MP0004270_analgesia | 2.60234507 |
| 9 | MP0003880_abnormal_central_pattern | 2.50204224 |
| 10 | MP0005645_abnormal_hypothalamus_physiol | 2.48698418 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.41800506 |
| 12 | MP0002638_abnormal_pupillary_reflex | 2.20526757 |
| 13 | MP0006276_abnormal_autonomic_nervous | 2.15792401 |
| 14 | MP0003283_abnormal_digestive_organ | 2.15235373 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.10498085 |
| 16 | MP0003121_genomic_imprinting | 2.08028337 |
| 17 | MP0009745_abnormal_behavioral_response | 2.05318263 |
| 18 | MP0001529_abnormal_vocalization | 2.03128466 |
| 19 | MP0000778_abnormal_nervous_system | 2.01554299 |
| 20 | MP0001984_abnormal_olfaction | 1.96955761 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 1.96765601 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 1.93804324 |
| 23 | MP0002735_abnormal_chemical_nociception | 1.87501333 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.82112270 |
| 25 | MP0001502_abnormal_circadian_rhythm | 1.82094497 |
| 26 | MP0002909_abnormal_adrenal_gland | 1.81042118 |
| 27 | MP0001486_abnormal_startle_reflex | 1.80447255 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.79255619 |
| 29 | MP0005423_abnormal_somatic_nervous | 1.76185691 |
| 30 | MP0002184_abnormal_innervation | 1.74431890 |
| 31 | MP0000566_synostosis | 1.70406963 |
| 32 | MP0002064_seizures | 1.66557532 |
| 33 | MP0000631_abnormal_neuroendocrine_gland | 1.61179002 |
| 34 | MP0002102_abnormal_ear_morphology | 1.59372701 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.58637335 |
| 36 | MP0009046_muscle_twitch | 1.57084490 |
| 37 | MP0002234_abnormal_pharynx_morphology | 1.57030781 |
| 38 | MP0002272_abnormal_nervous_system | 1.56534570 |
| 39 | MP0005379_endocrine/exocrine_gland_phen | 1.55055700 |
| 40 | MP0001968_abnormal_touch/_nociception | 1.53106619 |
| 41 | MP0000538_abnormal_urinary_bladder | 1.50062389 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.49520741 |
| 43 | MP0000678_abnormal_parathyroid_gland | 1.48583990 |
| 44 | MP0000462_abnormal_digestive_system | 1.47468995 |
| 45 | MP0005248_abnormal_Harderian_gland | 1.46591119 |
| 46 | MP0002067_abnormal_sensory_capabilities | 1.45472033 |
| 47 | MP0002751_abnormal_autonomic_nervous | 1.43669978 |
| 48 | MP0003890_abnormal_embryonic-extraembry | 1.40406476 |
| 49 | MP0001440_abnormal_grooming_behavior | 1.37200914 |
| 50 | MP0004142_abnormal_muscle_tone | 1.36612759 |
| 51 | MP0005386_behavior/neurological_phenoty | 1.34050424 |
| 52 | MP0004924_abnormal_behavior | 1.34050424 |
| 53 | MP0002733_abnormal_thermal_nociception | 1.31779186 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.27133612 |
| 55 | MP0001970_abnormal_pain_threshold | 1.26685543 |
| 56 | MP0002736_abnormal_nociception_after | 1.26564565 |
| 57 | MP0006072_abnormal_retinal_apoptosis | 1.26449507 |
| 58 | MP0003879_abnormal_hair_cell | 1.24314700 |
| 59 | MP0002693_abnormal_pancreas_physiology | 1.23338604 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.20173606 |
| 61 | MP0000569_abnormal_digit_pigmentation | 1.18718527 |
| 62 | MP0005410_abnormal_fertilization | 1.18564258 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.18430427 |
| 64 | MP0001944_abnormal_pancreas_morphology | 1.17238125 |
| 65 | MP0001346_abnormal_lacrimal_gland | 1.16257762 |
| 66 | MP0004043_abnormal_pH_regulation | 1.16010248 |
| 67 | MP0008789_abnormal_olfactory_epithelium | 1.15892255 |
| 68 | MP0005551_abnormal_eye_electrophysiolog | 1.12538654 |
| 69 | MP0003195_calcinosis | 1.12362492 |
| 70 | MP0002229_neurodegeneration | 1.11834423 |
| 71 | MP0004147_increased_porphyrin_level | 1.11418036 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.11220145 |
| 73 | MP0002882_abnormal_neuron_morphology | 1.10553897 |
| 74 | MP0000955_abnormal_spinal_cord | 1.09263141 |
| 75 | MP0003633_abnormal_nervous_system | 1.06575873 |
| 76 | MP0000026_abnormal_inner_ear | 1.04300905 |
| 77 | MP0004811_abnormal_neuron_physiology | 1.03702988 |
| 78 | MP0000579_abnormal_nail_morphology | 1.02242424 |
| 79 | MP0000427_abnormal_hair_cycle | 1.00813140 |
| 80 | MP0002163_abnormal_gland_morphology | 0.96582169 |
| 81 | MP0008057_abnormal_DNA_replication | 0.95700541 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95365862 |
| 83 | MP0008995_early_reproductive_senescence | 0.94447354 |
| 84 | MP0005253_abnormal_eye_physiology | 0.94334795 |
| 85 | MP0004742_abnormal_vestibular_system | 0.93694417 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 0.93684140 |
| 87 | MP0001963_abnormal_hearing_physiology | 0.92861676 |
| 88 | MP0000015_abnormal_ear_pigmentation | 0.92358895 |
| 89 | MP0003718_maternal_effect | 0.92196446 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.91892559 |
| 91 | MP0003698_abnormal_male_reproductive | 0.91870550 |
| 92 | MP0002152_abnormal_brain_morphology | 0.91142054 |
| 93 | MP0002066_abnormal_motor_capabilities/c | 0.90236180 |
| 94 | MP0004264_abnormal_extraembryonic_tissu | 0.89120632 |
| 95 | MP0001905_abnormal_dopamine_level | 0.88358890 |
| 96 | MP0002938_white_spotting | 0.88276581 |
| 97 | MP0008569_lethality_at_weaning | 0.88174584 |
| 98 | MP0002752_abnormal_somatic_nervous | 0.87526829 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.86450808 |
| 100 | MP0002069_abnormal_eating/drinking_beha | 0.85968806 |
| 101 | MP0000383_abnormal_hair_follicle | 0.85462662 |
| 102 | MP0001177_atelectasis | 0.85352812 |
| 103 | MP0000372_irregular_coat_pigmentation | 0.85065978 |
| 104 | MP0005499_abnormal_olfactory_system | 0.84902113 |
| 105 | MP0005394_taste/olfaction_phenotype | 0.84902113 |
| 106 | MP0004133_heterotaxia | 0.84591212 |
| 107 | MP0001765_abnormal_ion_homeostasis | 0.84248317 |
| 108 | MP0000613_abnormal_salivary_gland | 0.84111767 |
| 109 | MP0008872_abnormal_physiological_respon | 0.83806086 |
| 110 | MP0005195_abnormal_posterior_eye | 0.82931410 |
| 111 | MP0000013_abnormal_adipose_tissue | 0.82051263 |
| 112 | MP0005187_abnormal_penis_morphology | 0.82015125 |
| 113 | MP0004885_abnormal_endolymph | 0.81503875 |
| 114 | MP0008877_abnormal_DNA_methylation | 0.81501540 |
| 115 | MP0003631_nervous_system_phenotype | 0.81402812 |
| 116 | MP0000516_abnormal_urinary_system | 0.80641783 |
| 117 | MP0005367_renal/urinary_system_phenotyp | 0.80641783 |
| 118 | MP0003119_abnormal_digestive_system | 0.80622393 |
| 119 | MP0000681_abnormal_thyroid_gland | 0.80454875 |
| 120 | MP0002877_abnormal_melanocyte_morpholog | 0.80394412 |
| 121 | MP0001664_abnormal_digestion | 0.80101314 |
| 122 | MP0002822_catalepsy | 0.79996310 |
| 123 | MP0004085_abnormal_heartbeat | 0.78955285 |
| 124 | MP0003861_abnormal_nervous_system | 0.78832957 |
| 125 | MP0002928_abnormal_bile_duct | 0.77830406 |
| 126 | MP0000537_abnormal_urethra_morphology | 0.75840743 |
| 127 | MP0002160_abnormal_reproductive_system | 0.73301161 |
| 128 | MP0002653_abnormal_ependyma_morphology | 0.66776425 |
| 129 | MP0003137_abnormal_impulse_conducting | 0.66588751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.69030642 |
| 2 | Febrile seizures (HP:0002373) | 3.85212483 |
| 3 | Atonic seizures (HP:0010819) | 3.43148275 |
| 4 | Papillary thyroid carcinoma (HP:0002895) | 3.25970101 |
| 5 | Abnormal hair whorl (HP:0010721) | 3.06004664 |
| 6 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.03176208 |
| 7 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.03176208 |
| 8 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.98451965 |
| 9 | Nephronophthisis (HP:0000090) | 2.97419515 |
| 10 | Agitation (HP:0000713) | 2.90578158 |
| 11 | Gait imbalance (HP:0002141) | 2.90437533 |
| 12 | Epileptic encephalopathy (HP:0200134) | 2.89069636 |
| 13 | Focal seizures (HP:0007359) | 2.79393719 |
| 14 | Abnormality of the corticospinal tract (HP:0002492) | 2.79085641 |
| 15 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.76425494 |
| 16 | Medial flaring of the eyebrow (HP:0010747) | 2.76215617 |
| 17 | Decreased circulating renin level (HP:0003351) | 2.74685921 |
| 18 | Failure to thrive in infancy (HP:0001531) | 2.74308884 |
| 19 | Nephrogenic diabetes insipidus (HP:0009806) | 2.74043278 |
| 20 | Abnormality of the labia minora (HP:0012880) | 2.70084167 |
| 21 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.67259594 |
| 22 | Protruding tongue (HP:0010808) | 2.63717377 |
| 23 | Progressive cerebellar ataxia (HP:0002073) | 2.62233097 |
| 24 | Congenital primary aphakia (HP:0007707) | 2.61525371 |
| 25 | Abnormality of the renal medulla (HP:0100957) | 2.61440508 |
| 26 | Pancreatic fibrosis (HP:0100732) | 2.58176649 |
| 27 | Absence seizures (HP:0002121) | 2.55696594 |
| 28 | Pachygyria (HP:0001302) | 2.55457238 |
| 29 | Tubulointerstitial abnormality (HP:0001969) | 2.53079694 |
| 30 | Absent speech (HP:0001344) | 2.50817939 |
| 31 | Labial hypoplasia (HP:0000066) | 2.48852897 |
| 32 | Symptomatic seizures (HP:0011145) | 2.48099130 |
| 33 | Excessive salivation (HP:0003781) | 2.46395438 |
| 34 | Drooling (HP:0002307) | 2.46395438 |
| 35 | Myokymia (HP:0002411) | 2.43270608 |
| 36 | Inability to walk (HP:0002540) | 2.42857577 |
| 37 | Hypothermia (HP:0002045) | 2.41097210 |
| 38 | Abnormality of the renal cortex (HP:0011035) | 2.37867113 |
| 39 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.37846428 |
| 40 | Hypoplastic female external genitalia (HP:0012815) | 2.29784771 |
| 41 | True hermaphroditism (HP:0010459) | 2.28981908 |
| 42 | Hyperactive renin-angiotensin system (HP:0000841) | 2.28412220 |
| 43 | Visual hallucinations (HP:0002367) | 2.27404613 |
| 44 | Epileptiform EEG discharges (HP:0011182) | 2.27062621 |
| 45 | Dialeptic seizures (HP:0011146) | 2.26701165 |
| 46 | Hyperventilation (HP:0002883) | 2.26674828 |
| 47 | Urinary urgency (HP:0000012) | 2.24534690 |
| 48 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.23892736 |
| 49 | Chronic hepatic failure (HP:0100626) | 2.23616122 |
| 50 | Amyotrophic lateral sclerosis (HP:0007354) | 2.23433445 |
| 51 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.22387311 |
| 52 | Polyphagia (HP:0002591) | 2.20944834 |
| 53 | Hyperphosphatemia (HP:0002905) | 2.19797513 |
| 54 | Thyroid carcinoma (HP:0002890) | 2.19698742 |
| 55 | Poor coordination (HP:0002370) | 2.17627619 |
| 56 | Atelectasis (HP:0100750) | 2.17243648 |
| 57 | Genetic anticipation (HP:0003743) | 2.16020406 |
| 58 | Volvulus (HP:0002580) | 2.15318214 |
| 59 | Blue irides (HP:0000635) | 2.14810375 |
| 60 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.13499398 |
| 61 | Hypoplasia of the fovea (HP:0007750) | 2.13499398 |
| 62 | EEG with generalized epileptiform discharges (HP:0011198) | 2.12964413 |
| 63 | Sleep apnea (HP:0010535) | 2.12550335 |
| 64 | Oligodactyly (hands) (HP:0001180) | 2.09481847 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.08929712 |
| 66 | Generalized tonic-clonic seizures (HP:0002069) | 2.06909484 |
| 67 | Pancreatic cysts (HP:0001737) | 2.06446296 |
| 68 | Limb dystonia (HP:0002451) | 2.06435345 |
| 69 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.05969020 |
| 70 | Narrow forehead (HP:0000341) | 2.05457601 |
| 71 | Congenital sensorineural hearing impairment (HP:0008527) | 2.04932360 |
| 72 | Absent/shortened dynein arms (HP:0200106) | 2.04549236 |
| 73 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.04549236 |
| 74 | Retinal dysplasia (HP:0007973) | 2.04506097 |
| 75 | Absent eyebrow (HP:0002223) | 2.03640913 |
| 76 | Genital tract atresia (HP:0001827) | 2.03421588 |
| 77 | Tetany (HP:0001281) | 2.01848417 |
| 78 | Abnormal ciliary motility (HP:0012262) | 2.01577143 |
| 79 | Exotropia (HP:0000577) | 2.01167231 |
| 80 | Neoplasm of the adrenal cortex (HP:0100641) | 2.01039112 |
| 81 | Abolished electroretinogram (ERG) (HP:0000550) | 2.00739672 |
| 82 | Vaginal atresia (HP:0000148) | 2.00709807 |
| 83 | Attenuation of retinal blood vessels (HP:0007843) | 1.99524852 |
| 84 | Tubulointerstitial nephritis (HP:0001970) | 1.98204752 |
| 85 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.97837073 |
| 86 | Specific learning disability (HP:0001328) | 1.96685539 |
| 87 | Hypsarrhythmia (HP:0002521) | 1.95618163 |
| 88 | Postaxial hand polydactyly (HP:0001162) | 1.95452938 |
| 89 | Renal cortical cysts (HP:0000803) | 1.95449025 |
| 90 | Progressive inability to walk (HP:0002505) | 1.95142119 |
| 91 | Esotropia (HP:0000565) | 1.95130442 |
| 92 | Congenital stationary night blindness (HP:0007642) | 1.94523798 |
| 93 | Progressive sensorineural hearing impairment (HP:0000408) | 1.94334176 |
| 94 | Occipital encephalocele (HP:0002085) | 1.94288174 |
| 95 | Tented upper lip vermilion (HP:0010804) | 1.94196597 |
| 96 | Broad-based gait (HP:0002136) | 1.94022396 |
| 97 | Abnormality of the fovea (HP:0000493) | 1.91879355 |
| 98 | Bradycardia (HP:0001662) | 1.91750133 |
| 99 | Hip dysplasia (HP:0001385) | 1.89733932 |
| 100 | Narrow nasal bridge (HP:0000446) | 1.89627283 |
| 101 | Lissencephaly (HP:0001339) | 1.88968574 |
| 102 | Abnormality of macular pigmentation (HP:0008002) | 1.88788877 |
| 103 | Abnormality of renin-angiotensin system (HP:0000847) | 1.87264126 |
| 104 | Amblyopia (HP:0000646) | 1.87167470 |
| 105 | Molar tooth sign on MRI (HP:0002419) | 1.86773830 |
| 106 | Abnormality of midbrain morphology (HP:0002418) | 1.86773830 |
| 107 | Widely spaced teeth (HP:0000687) | 1.86353657 |
| 108 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.83863136 |
| 109 | Short foot (HP:0001773) | 1.82801849 |
| 110 | Postaxial foot polydactyly (HP:0001830) | 1.81548069 |
| 111 | Spastic tetraplegia (HP:0002510) | 1.81284884 |
| 112 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.81242019 |
| 113 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.81242019 |
| 114 | Generalized hypopigmentation of hair (HP:0011358) | 1.80450829 |
| 115 | Type II lissencephaly (HP:0007260) | 1.79850259 |
| 116 | Hyperkalemia (HP:0002153) | 1.79456857 |
| 117 | Polymicrogyria (HP:0002126) | 1.79388119 |
| 118 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.78854524 |
| 119 | Fair hair (HP:0002286) | 1.78807711 |
| 120 | Muscular hypotonia of the trunk (HP:0008936) | 1.78791373 |
| 121 | Cystic liver disease (HP:0006706) | 1.78729522 |
| 122 | Cupped ear (HP:0000378) | 1.77720535 |
| 123 | Shawl scrotum (HP:0000049) | 1.77710168 |
| 124 | Tubulointerstitial fibrosis (HP:0005576) | 1.77537910 |
| 125 | Intestinal atresia (HP:0011100) | 1.77257126 |
| 126 | Retinitis pigmentosa (HP:0000510) | 1.76033519 |
| 127 | Spastic gait (HP:0002064) | 1.75990781 |
| 128 | Intellectual disability, severe (HP:0010864) | 1.75793540 |
| 129 | Curly hair (HP:0002212) | 1.75607509 |
| 130 | Unilateral renal agenesis (HP:0000122) | 1.75517947 |
| 131 | Impaired vibratory sensation (HP:0002495) | 1.74378382 |
| 132 | Growth hormone deficiency (HP:0000824) | 1.73208099 |
| 133 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.73074400 |
| 134 | Termporal pattern (HP:0011008) | 1.73006198 |
| 135 | Insidious onset (HP:0003587) | 1.73006198 |
| 136 | Anosmia (HP:0000458) | 1.72337877 |
| 137 | Hepatoblastoma (HP:0002884) | 1.72097161 |
| 138 | Abnormal eating behavior (HP:0100738) | 1.71360404 |
| 139 | Optic nerve hypoplasia (HP:0000609) | 1.70708546 |
| 140 | Hyperthyroidism (HP:0000836) | 1.69309849 |
| 141 | Facial cleft (HP:0002006) | 1.69232691 |
| 142 | Abnormality of salivation (HP:0100755) | 1.69129331 |
| 143 | Gaze-evoked nystagmus (HP:0000640) | 1.68876608 |
| 144 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.68503124 |
| 145 | Hypoplasia of the brainstem (HP:0002365) | 1.68503124 |
| 146 | Preaxial hand polydactyly (HP:0001177) | 1.68424412 |
| 147 | Abnormal pancreas size (HP:0012094) | 1.68214842 |
| 148 | Abnormality of the labia (HP:0000058) | 1.66778875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.19338165 |
| 2 | CASK | 3.90034970 |
| 3 | NTRK3 | 3.62814205 |
| 4 | FRK | 3.30301369 |
| 5 | SIK3 | 3.20593214 |
| 6 | MARK1 | 3.18975274 |
| 7 | MAP2K7 | 3.01105879 |
| 8 | MAP4K2 | 2.71449029 |
| 9 | TRIM28 | 2.71442538 |
| 10 | MAP3K4 | 2.45731870 |
| 11 | MAPK13 | 2.30927691 |
| 12 | AKT3 | 2.19301836 |
| 13 | BCR | 2.06082454 |
| 14 | KSR1 | 2.03171926 |
| 15 | SGK2 | 1.79342322 |
| 16 | PRPF4B | 1.64952038 |
| 17 | LATS1 | 1.59625071 |
| 18 | NTRK2 | 1.58424552 |
| 19 | WNK3 | 1.56160045 |
| 20 | EPHA4 | 1.52337584 |
| 21 | TNIK | 1.51559124 |
| 22 | MAP3K9 | 1.36309441 |
| 23 | BMPR1B | 1.35312372 |
| 24 | ACVR1B | 1.32219516 |
| 25 | VRK1 | 1.31975571 |
| 26 | SGK494 | 1.30577566 |
| 27 | SGK223 | 1.30577566 |
| 28 | MINK1 | 1.29879954 |
| 29 | PRKD3 | 1.22067439 |
| 30 | STK38L | 1.11777511 |
| 31 | CDK19 | 1.11509920 |
| 32 | MAPK15 | 1.10467332 |
| 33 | TAOK2 | 1.09991702 |
| 34 | CCNB1 | 1.09981065 |
| 35 | CDK3 | 1.08538577 |
| 36 | FER | 1.07485298 |
| 37 | GRK1 | 1.07002578 |
| 38 | TAOK3 | 1.02977200 |
| 39 | MAP3K6 | 1.02059859 |
| 40 | MAP2K4 | 1.01006266 |
| 41 | MAP3K12 | 1.00120317 |
| 42 | BMPR2 | 0.99283587 |
| 43 | PLK2 | 0.99162487 |
| 44 | CDK8 | 0.97291241 |
| 45 | CSNK1G2 | 0.94458485 |
| 46 | PRKCE | 0.93739031 |
| 47 | SGK3 | 0.92203006 |
| 48 | DYRK1A | 0.89972653 |
| 49 | STK38 | 0.88414197 |
| 50 | PLK3 | 0.87865266 |
| 51 | DYRK2 | 0.85367872 |
| 52 | UHMK1 | 0.85247526 |
| 53 | SIK2 | 0.85218703 |
| 54 | IRAK2 | 0.84797746 |
| 55 | LATS2 | 0.80837414 |
| 56 | STK39 | 0.80012322 |
| 57 | CDK5 | 0.79416993 |
| 58 | MKNK2 | 0.79277083 |
| 59 | ADRBK2 | 0.79201051 |
| 60 | EPHB2 | 0.78048264 |
| 61 | CAMK2A | 0.76916262 |
| 62 | CDC42BPA | 0.76792051 |
| 63 | PAK6 | 0.74724788 |
| 64 | IRAK1 | 0.73555542 |
| 65 | CAMK1G | 0.69042797 |
| 66 | PRKAA1 | 0.68685740 |
| 67 | PAK3 | 0.68678765 |
| 68 | BRAF | 0.68055905 |
| 69 | SGK1 | 0.67634131 |
| 70 | FGFR2 | 0.66839499 |
| 71 | ERBB3 | 0.66597372 |
| 72 | SRPK1 | 0.66262476 |
| 73 | DYRK3 | 0.66035878 |
| 74 | PRKCG | 0.64841631 |
| 75 | HIPK2 | 0.64055518 |
| 76 | MUSK | 0.63965191 |
| 77 | CAMK2B | 0.62719345 |
| 78 | EIF2AK2 | 0.59436930 |
| 79 | MARK2 | 0.58990878 |
| 80 | MAP3K2 | 0.58341264 |
| 81 | CSNK1A1L | 0.57958308 |
| 82 | ADRBK1 | 0.54959524 |
| 83 | CAMK1 | 0.54942215 |
| 84 | NEK6 | 0.54590226 |
| 85 | CAMK1D | 0.53317849 |
| 86 | CSNK1G1 | 0.52374214 |
| 87 | PKN1 | 0.52169325 |
| 88 | PNCK | 0.52051294 |
| 89 | PHKG1 | 0.52011029 |
| 90 | PHKG2 | 0.52011029 |
| 91 | CAMKK2 | 0.51925602 |
| 92 | EPHA3 | 0.51264797 |
| 93 | NUAK1 | 0.50849128 |
| 94 | ERBB4 | 0.49986748 |
| 95 | PASK | 0.49660709 |
| 96 | CSNK1G3 | 0.48339914 |
| 97 | CSNK1D | 0.47779914 |
| 98 | PINK1 | 0.46582739 |
| 99 | MKNK1 | 0.45505915 |
| 100 | BRD4 | 0.45136327 |
| 101 | BCKDK | 0.44947449 |
| 102 | PLK4 | 0.44847893 |
| 103 | DYRK1B | 0.44620132 |
| 104 | YES1 | 0.44571198 |
| 105 | RPS6KA4 | 0.44461550 |
| 106 | CAMK4 | 0.44365909 |
| 107 | PRKACB | 0.43551066 |
| 108 | PRKD2 | 0.42941650 |
| 109 | DAPK2 | 0.42730064 |
| 110 | LMTK2 | 0.40033632 |
| 111 | PRKACA | 0.38386221 |
| 112 | WNK4 | 0.38003812 |
| 113 | STK11 | 0.37845797 |
| 114 | PRKG1 | 0.37700569 |
| 115 | OXSR1 | 0.37652581 |
| 116 | PRKCH | 0.37588983 |
| 117 | PIK3CA | 0.37355179 |
| 118 | TNK2 | 0.37278842 |
| 119 | PRKAA2 | 0.36198444 |
| 120 | IRAK3 | 0.35742954 |
| 121 | PRKCB | 0.35540630 |
| 122 | PRKCZ | 0.33762801 |
| 123 | CSNK1A1 | 0.33470528 |
| 124 | ZAK | 0.32717819 |
| 125 | KSR2 | 0.32441156 |
| 126 | CSNK1E | 0.31671967 |
| 127 | EGFR | 0.31619614 |
| 128 | PIK3CG | 0.27605143 |
| 129 | RPS6KA5 | 0.27493089 |
| 130 | RPS6KA3 | 0.25014757 |
| 131 | ATM | 0.23282242 |
| 132 | PRKACG | 0.23221019 |
| 133 | MATK | 0.22431409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.45596908 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.95432376 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 2.71615442 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.39209252 |
| 5 | Taste transduction_Homo sapiens_hsa04742 | 2.31198895 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.27878888 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24346215 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.23575729 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.15394722 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.14975447 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.12980657 |
| 12 | Cocaine addiction_Homo sapiens_hsa05030 | 2.10351703 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.00098275 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95298239 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.92877035 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.90348940 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.82207101 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.79130919 |
| 19 | Phototransduction_Homo sapiens_hsa04744 | 1.77165446 |
| 20 | Circadian rhythm_Homo sapiens_hsa04710 | 1.76979314 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.59839845 |
| 22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.59391912 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.54905426 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51411456 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.48603248 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.41449198 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.29712705 |
| 28 | Salivary secretion_Homo sapiens_hsa04970 | 1.28646160 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.26533792 |
| 30 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.26489023 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.24433058 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24181966 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.24175899 |
| 34 | Axon guidance_Homo sapiens_hsa04360 | 1.19743143 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.19581446 |
| 36 | Protein export_Homo sapiens_hsa03060 | 1.18517118 |
| 37 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.18110732 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.17808586 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.14495425 |
| 40 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.14161235 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.14074151 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13440572 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12407871 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11561275 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10139532 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.08458985 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07661078 |
| 48 | Endometrial cancer_Homo sapiens_hsa05213 | 1.04276396 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04214912 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03336438 |
| 51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.02030546 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 1.01789933 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98444861 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 0.97882243 |
| 55 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.96104079 |
| 56 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.96051468 |
| 57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94136448 |
| 58 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.93831673 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87991172 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.87233193 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86283682 |
| 62 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.85496735 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85246127 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84588345 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.83253344 |
| 66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.82220708 |
| 67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80264664 |
| 68 | Alcoholism_Homo sapiens_hsa05034 | 0.79933237 |
| 69 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.79249855 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78890735 |
| 71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77312027 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76650973 |
| 73 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75124772 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74286467 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.73995926 |
| 76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72593489 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71439665 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70908543 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68928249 |
| 80 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67676203 |
| 81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67346579 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66181087 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65263598 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64510263 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63412536 |
| 86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.63023295 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62186625 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62087769 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61694887 |
| 90 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61082406 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59448596 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59020101 |
| 93 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.58543894 |
| 94 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.58514697 |
| 95 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58018553 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56874270 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.56849578 |
| 98 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56504341 |
| 99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55598668 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55083743 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54505429 |
| 102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.53682149 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53606745 |
| 104 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53453662 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.52435823 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49913185 |
| 107 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49288318 |
| 108 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49242165 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48626702 |
| 110 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48333340 |
| 111 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48159995 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47753109 |
| 113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47215120 |
| 114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46762506 |
| 115 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.45854930 |
| 116 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45277457 |
| 117 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.44895479 |
| 118 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44471263 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44258676 |
| 120 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44008837 |
| 121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42507922 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41459439 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40766906 |
| 124 | RNA degradation_Homo sapiens_hsa03018 | 0.40587257 |
| 125 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40580696 |
| 126 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40576966 |
| 127 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39095449 |
| 128 | Basal transcription factors_Homo sapiens_hsa03022 | 0.38665656 |
| 129 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37922673 |
| 130 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37700801 |
| 131 | Prostate cancer_Homo sapiens_hsa05215 | 0.37277526 |
| 132 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36719168 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36337403 |
| 134 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32298714 |
| 135 | Asthma_Homo sapiens_hsa05310 | 0.29927536 |
| 136 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.28033809 |

